A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1999
12/23/1999	WO1999065915A1 Polymorphic clopidogrel hydrogenesulphate form
12/23/1999	WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999	WO1999065306A1 Methods for reducing levels of homocysteine and c-reactive protein
12/23/1999	WO1999051741A3 Lyst protein complexes and lyst interacting proteins
12/23/1999	DE19827640A1 New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
12/23/1999	CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999	CA2333384A1 Methods for reducing levels of homocysteine and c-reactive protein
12/22/1999	EP0965638A2 G-CSF analog compositions and methods
12/22/1999	EP0964856A1 Bicyclic amino acids
12/22/1999	EP0964684A1 Crystalline pharmaceutical product
12/22/1999	EP0684953A4 Adenosine kinase inhibitors comprising lyxofuranosyl derivatives.
12/22/1999	CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4)
12/22/1999	CN1239480A Pharmaceutical compsns. containing an MPL ligand
12/22/1999	CN1238988A Medicine for treating apoplexy and its preparing process
12/22/1999	CN1238953A Notoginseng medicine for oral application
12/21/1999	US6005091 Nucleic acids encoding immunoglobulin domains
12/21/1999	US6005082 Process for purification of factor VIII
12/21/1999	US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis
12/21/1999	US6005077 Use of von willebrand factor and pharmaceutical formulation
12/21/1999	US6005020 Bioresorbable compositions for implantable prostheses
12/21/1999	US6004985 Thio acid derived monocylic N-heterocyclics as anticoagulants
12/21/1999	US6004555 Methods for the specific coagulation of vasculature
12/21/1999	US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell
12/21/1999	CA2150552C Antithrombotic
12/21/1999	CA2143510C Method for the isolation and purification of vitamin k-dependent proteins
12/16/1999	WO1999064622A1 Inhibition of coagulation in blood and blood products
12/16/1999	WO1999064446A1 Pyrazinone protease inhibitors
12/16/1999	WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999	WO1999064400A1 INHIBITORS OF p38
12/16/1999	WO1999064072A1 Conjugate consisting of a lectin and a blood coagulation factor
12/16/1999	WO1999064004A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE
12/16/1999	WO1999057251A3 Thrombolytic agents derived from streptokinase
12/16/1999	CA2334970A1 Quinazolinone inhibitors of cgmp phosphodiesterase
12/16/1999	CA2334945A1 Imidazolyl derivatives
12/16/1999	CA2333890A1 Inhibition of coagulation in blood and blood products
12/15/1999	EP0963757A2 Hemostatic agent
12/15/1999	EP0963431A1 NOVEL FabH
12/15/1999	EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999	EP0642504B1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
12/15/1999	CN1238773A Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
12/15/1999	CN1238765A N-(imidazoly (butyl) benzenesulphonamide derivatives with anticoagulation active
12/15/1999	CN1238693A Pharmaceutical composition comprising compound having anti-Xa activity and platelet aggregation antagonist compound
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001882 Photoactivated hypericin and the use thereof
12/14/1999	US6001830 Heterocyclic compounds
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001355 Dosage units comprising a human tissue plasminogen activator (tpa) and pro-tpa (a precursor of tpa) in specific ratios in compatible medium; pro-tpa has a higher affinity for fibrin and better selectivity than tpa
12/14/1999	US6001259 Preparation of autologous plasma and fibrin gel
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2155910C Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
12/14/1999	CA2065150C Inhibitors of thrombin
12/09/1999	WO1999063070A1 Human protein c polypeptide
12/09/1999	WO1999062914A1 Cyclic boroproline compounds
12/09/1999	WO1999062904A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999	CA2333994A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	CA2330171A1 Human protein c polypeptide
12/08/1999	EP0775158B1 Cyclopeptolides
12/08/1999	CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/08/1999	CN1237958A New manufacturing process of metoprolol
12/07/1999	US5998579 Epimorphin antagonist and process for producing it
12/07/1999	US5997867 Method of using humanized antibody against CD18
12/07/1999	US5997865 Agonist antibodies against the flk2/flt3 receptor and uses thereof
12/07/1999	US5997860 Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines
12/07/1999	US5997857 Co-administration of interleukin-3 mutants with colony stimulating factors
12/07/1999	CA2157410C Enhanced circulation effector composition and method
12/02/1999	WO1999061617A1 Interleukins-21 and 22
12/02/1999	WO1999061600A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
12/02/1999	WO1999061595A2 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999	WO1999061481A1 Amphiphilic polysaccharide derivatives
12/02/1999	WO1999061471A2 Human transmembrane proteins
12/02/1999	WO1999061445A1 G-csf mimetics
12/02/1999	WO1999061442A1 Imidazopyridine thrombin inhibitors
12/02/1999	WO1999061440A1 Novel substituted imidazole compounds
12/02/1999	WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	WO1999061427A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999	WO1999061072A2 Methods of inhibiting clot formation
12/02/1999	WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999	WO1999045938B1 Thrombin preparation and products and fibrin sealant methods employing same
12/02/1999	CA2333592A1 Methods of inhibiting clot formation
12/02/1999	CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999	CA2333157A1 Novel substituted imidazole compounds
12/02/1999	CA2333040A1 Imidazopyridine thrombin inhibitors
12/02/1999	CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	CA2332318A1 G-csf mimetics
12/02/1999	CA2329274A1 Interleukin-21
12/02/1999	CA2329143A1 Adeno-associated viral vector-mediated expression of factor viii activity
12/02/1999	CA2329072A1 Human transmembrane proteins
12/01/1999	EP0960130A1 Oxygen-binding heme proteins incorporating circularly-permuted globins
12/01/1999	EP0960104A1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
12/01/1999	EP0960102A1 AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN
12/01/1999	EP0960098A1 Arylsulfonyl hydroxamic acid derivatives
12/01/1999	EP0959878A1 Method for treating renal failure
12/01/1999	EP0850235B1 Quinolein-2(1h)-one derivatives as serotonin antagonists
12/01/1999	EP0788491B1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
12/01/1999	EP0576612B1 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
12/01/1999	CN1237168A Bicyclic aryl carboxamides and their therapeutic use
11/1999
11/30/1999	US5994375 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
11/30/1999	US5994356 Carboxylic acid derivatives, medicaments comprising these compounds, their use and processes for their production
11/30/1999	US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders

1 ... 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 ... 671